Noninvasive prenatal testing (NIPT) is an advancing evaluating system for pregnant ladies. It looks at the cell-free Deoxyribonucleic Acid (DNA) of both baby and the mother. It gives an analysis of hereditary screening utilizing just single cylinder blood. NIPT gives expectations about the nonappearance or presence of hereditary irregularity in the hatchling. It includes a straightforward strategy for blood withdrawal yet presents top-notch viability for the discovery of trisomy by limiting the quantity of performing further invasive testing methodology. NIPT is performed to recognize specific hereditary abnormalities like absent or additional duplicates of trisomy 18, X and Y chromosomes, Down syndrome, and trisomy 13. With mechanical progressions sooner rather than later, NIPT will actually want to distinguish other hereditary abnormalities.
For example, in June 2017, Illumina, Inc., an American organization, teamed up with Next Generation Genomic Co., Ltd., the Association of Southeast Asian Nations (ASEAN) pioneers in research facility administrations and regenerative science. This collusion will permit huge patient admittance to Illumina under cutting-edge sequencing for NIPT.
Request FREE Sample Report (Including Full TOC, Table & Figures) @
https://www.coherentmarketinsights.com/insight/request-sample/4916
Expanding item dispatches are supposed to drive the market development over the figure period.
For example, in May 2017, Natera Inc., a clinical hereditary testing organization, sent off ‘Vistara’, a non-invasive prenatal test (NIPT). It is intended to screen single-quality problems.
Effect of COVID-19
The COVID-19 flare-up was first covered on December 31, 2019, in Wuhan, China. As per the WHO, over 265,713,467 cases and 5,260,888 passings due to the Covid were accounted for till December 07, 2021, across the globe.
The COVID-19 pandemic and ensuing lockdown in different nations have harmed the monetary status of organizations across all areas. The COVID-19 pandemic has affected the whole production network of the medical services industry predominantly because of severe lockdown in a few districts. Moreover, it is normal to altogether affect the North Africa non-invasive prenatal testing (NIPT) market, regarding both demand and supply.
Society for Maternal-Fetal Medicine (SMFM) proposes that the number of ultrasound arrangements in the principal trimester can be diminished by carrying out one ultrasound assessment for dating and nuchal clarity (NT) to decrease the possibilities of COVID-19 openness. NIPT can be performed at home using remote administrations, for example, portable blood draw organizations. This will assist with keeping up with eager mother’s security during the pandemic with the least friendly contact.
The presence of elective techniques for prenatal findings is supposed to be a central point impeding the North Africa non-invasive prenatal testing market development over the figure period.
For example, amniocentesis and chorion biopsy are two elective strategies that are utilized in prenatal determination. Amniocentesis is a clinical trial utilized for the prenatal conclusion and sex assurance. Chorion biopsy, otherwise called Chorionic villus examining (CVS), is one more diagnostic test performed during pregnancy to decide whether an unborn youngster is in danger of innate deformities.
NIPT in view of sans cell DNA analysis from maternal blood is a screening test with specific possibilities of misleading positive and adverse outcomes. Moreover, NIPT doesn’t screen for birth deformities, for example, open brain tube abandons, or different circumstances like mental imbalance. NIPT tests likewise don’t evaluate for polyploidy (for example triploidy) or single-quality problems. Such restrictions are supposed to hamper the development of North Africa non-invasive prenatal testing market.
Download PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4916
Key members working in North Africa non-invasive prenatal testing market incorporate Quest Diagnostics Incorporated, BGI Group, Laboratory Corporation of America Holdings (LabCorp), Yourgene Health Plc., Natera, Inc., F. Hoffmann-La Roche AG, PerkinElmer, Inc., Eurofins Scientific, and Illumina, Inc.
Reasons to buy this North Africa Non-Invasive Prenatal Testing Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ North Africa Non-Invasive Prenatal Testing market size estimation and recent advancements in the industry are explained.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/4916
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Country
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Mergers & Acquisitions, Collaborations & Partnerships
- Product Approval and Launch
- Technology Evolution
- Ethical Concerns
- PEST Analysis
- Epidemiology
- Market Dynamics
- North Africa Non-invasive Prenatal Testing Market – Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- North Africa Non-invasive Prenatal Testing Market, By Application, 2021 – 2028, (US$ Mn.)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Trisomy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Microdeletion Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Sex Chromosome Abnormalities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Introduction
- North Africa Non-invasive Prenatal Testing Market, By End User, 2021 – 2028, (US$ Mn.)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Diagnostic Centers & Independent Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Introduction
- North Africa Non-invasive Prenatal Testing Market, By Country, 2021 – 2028, (US$ Mn.)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2028
- Egypt
- Market Size and Forecast, By Application, 2017 – 2028, (US$ Mn.)
- Market Size and Forecast, By End User, 2017 – 2028, (US$ Mn.)
- Algeria
- Market Size and Forecast, By Application, 2017 – 2028, (US$ Mn.)
- Market Size and Forecast, By End User, 2017 – 2028, (US$ Mn.)
- (US$ Mn.)
- Morocco
- Market Size and Forecast, By Application, 2017 – 2028, (US$ Mn.)
- Market Size and Forecast, By End User, 2017 – 2028, (US$ Mn.)
- Rest of North Africa
- Market Size and Forecast, By Application, 2017 – 2028, (US$ Mn.)
- Market Size and Forecast, By End User, 2017 – 2028, (US$ Mn.)
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Quest Diagnostics Incorporated
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Illumina, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eurofins Scientific
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PerkinElmer, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Natera, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Yourgene Health plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Laboratory Corporation of America Holdings (LabCorp)
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BGI Group
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Quest Diagnostics Incorporated
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com